BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Meridian Co. Ltd. (MRDAF) Recieves Standard And Poor's Complete Corporate Listing


10/19/2005 5:10:29 PM

VANCOUVER, British Columbia--(BUSINESS WIRE)--March 17, 2004--Meridian Co., Ltd. ("Meridian" or the "Company") (NASD OTC-BB: MRDAF) a leading supplier of integrative medical devices, is pleased to announce today that the Editorial Board of Standard and Poor's ("S&P") approved Meridian for a complete corporate listing and description in the Standard and Poor's Corporation Records.

Additionally, Meridian will have its corporate description published in Standard and Poor's Daily News Section. S&P also will initiate financial coverage of Meridian as part of the S&P Market Access Program, including coverage of Meridian on the S&P Internet site, www.advisorinsight.com, the S&P Marketscope and the electronic version of the S&P Stock Guide database. Additionally, S&P's coverage of Meridian will appear on the highly trafficked OTC Bulletin Board Internet site, www.otcbb.com.

Standard & Poor's Corporation Records is a recognized securities manual for the "Blue Sky" Standard Manual Exemption for secondary trading in more than 35 states, Meridian currently qualifies for this Exemption in 47 states. Meridian's listing in Standard & Poor's Corporation Records should assist the brokerage and investment communities in making a market for Meridian's stock. It is recommended that brokers check with their compliance officers or legal counsel for applicable "Blue Sky" laws and regulations pertaining to them.

About Meridian

Meridian is an established leader in the research, development, manufacturing and sales of integrative medical devices successfully marketed to a wide variety of health care practitioners worldwide. The products have FDA and other recognized regulatory approvals as well as 18 registered patents on its technology. The Company is committed to ongoing clinical research for the globalization and advancement of integrative medical products that contribute to the better health of humanity.

This release contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

Contacts

Meridian Co., Ltd. Craig Auringer, 604-647-0044 or Toll Free: 1-866-802-1222 Website: www.meridianmedical.ca



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES